A health economic evaluation of the multinational, randomized controlled CONVINCE trial: cost-utility of high-dose online hemodiafiltration compared to high-flux hemodialysisAniek E.M. Schouten, Krister Cromm, Andrew Davenport et al.|Kidney International|2025Cited by 17
Exploratory Post Hoc Analysis of the CONVINCE Randomized Controlled Trial: Differential Treatment Effects of Hemodiafiltration (HDF) and Hemodialysis (HD) on Quality of LifeKrister Cromm, Matthias Rose, Felix Fischer et al.|Journal of the American Society of Nephrology|2024Cited by 0
Patient-Reported Health Status of Adults with Kidney Failure Receiving Hemodiafiltration vs. Hemodialysis: Results from the CONVINCE Randomized Controlled Clinical TrialMatthias Rose, P. J. Blankestijn, Felix Fischer et al.|Journal of the American Society of Nephrology|2023Cited by 0
Correction: Frequent hemodialysis versus standard hemodialysis for people with kidney failure: Systematic review and meta-analysis of randomized controlled trialsPatrizia Natale, Giovanni Strippoli, Suetonia C. Green et al.|PLoS ONE|2025Cited by 0
Convective Volume, Patient Anthropometric Characteristics, and Risk of All-Cause Mortality in Hemodiafiltration: A Cohort StudyKrister Cromm, Giovanni Strippoli, Robin W.M. Vernooij et al.|Journal of the American Society of Nephrology|2025Cited by 0